Point72 Asia (Singapore)’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,844	Closed	-$223K	–	1050
2024 Q3	$223K	Buy	3,844 +1,033	+37%	+$60K	0.04%	346
2024 Q2	$128K	Buy	+2,811	New	+$128K	0.03%	416